Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
After experiencing a medical emergency, Don Cohn is giving back to the department that he credits with saving his life.
As bandwidth demands on today’s computers reach their limit, scientists are developing systems with new materials that can match the speed and precision of animal nervous systems. UC San Diego physicists have now simulated the foundation of new types of computing devices that mimic brain functions.
UC San Diego School of Medicine receives $2.6M to fund their PRIME-Health Equity program and launch a new program on Native American health. These medical education programs provide financial support to medical students interested in addressing health disparities and serving local communities.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.
Lab studies reveal protein HSP27’s role in blood vessel leakage, opening the possibility that therapeutically dialing its activity up or down might stabilize patients with sepsis.
UC San Diego researchers developed first-of-their-kind lung organoids that include all cell types that make up the organ, allowing for “Phase 0” testing of new treatments for respiratory infections such as COVID-19.
Publishing in the journal Science, a research team led by new UC San Diego biologist Alexandra Dickinson has identified a compound that plays a key role in triggering the development of plants’ lateral roots. Retinoids, known for medical uses, were found to be vital in plant growth.